Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher E Brightling

Showing results (181-190 of 296) with videos related to

Pageof 30
Sort By:
Respiratory Research|January 20, 2026
Effectiveness of biologics for reducing occlusive mucus plugs in patients with severe asthma: a systematic reviewHelena Aegerter, Christopher E Brightling, Eleanor M Dunican, et al.
The Lancet. Respiratory Medicine|January 26, 2023
Long-term safety and efficacy of tezepelumab in people with severe, uncontrolled asthma (DESTINATION): a randomised, placebo-controlled extension studyAndrew Menzies-Gow, Michael E Wechsler, Christopher E Brightling, et al.
American Journal of Respiratory and Critical Care Medicine|February 8, 2024
Biomarkers Associated with Lung Function Decline and Dupilumab Response in Patients with AsthmaIan D Pavord, Lucia De Prado Gómez, Guy Brusselle, et al.
The European Respiratory Journal|May 3, 2017
Associations in asthma between quantitative computed tomography and bronchial biopsy-derived airway remodellingRachid Berair, Ruth Hartley, Vijay Mistry, et al.
The Journal of Allergy and Clinical Immunology|July 1, 2025
Analysis of airway inflammation demonstrates a mechanism for T2-biologic failure in asthmaP Jane McDowell, Adnan Azim, John Busby, et al.
Respiratory Medicine|September 1, 2016
Effects of older age and age of asthma onset on clinical and inflammatory variables in severe refractory asthmaRekha Chaudhuri, Charles McSharry, Liam G Heaney, et al.
ERJ Open Research|August 5, 2021
High serum granulocyte-colony stimulating factor characterises neutrophilic COPD exacerbations associated with dysbiosisArindam Chakrabarti, Jordan S Mar, David F Choy, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|May 2, 2024
Biomarkers and clinical outcomes after tezepelumab cessation: Extended follow-up from the 2-year DESTINATION studyChristopher E Brightling, Marco Caminati, Jean-Pierre Llanos, et al.
Respiratory Research|July 31, 2010
Expression and activation of the oxytocin receptor in airway smooth muscle cells: Regulation by TNFalpha and IL-13Yassine Amrani, Farhat Syed, Chris Huang, et al.
The Lancet. Respiratory Medicine|December 8, 2024
Augmenting clinical trials in asthma through digital technology, decentralised designs, and person-centric endpoints: opportunities and challengesJob F M van Boven, Richard W Costello, Kit C B Roes, et al.
Pageof 30

Showing results (181-190 of 296) with videos related to

Sort By:
Pageof 30
Respiratory Research|January 20, 2026
Effectiveness of biologics for reducing occlusive mucus plugs in patients with severe asthma: a systematic reviewHelena Aegerter, Christopher E Brightling, Eleanor M Dunican, et al.
The Lancet. Respiratory Medicine|January 26, 2023
Long-term safety and efficacy of tezepelumab in people with severe, uncontrolled asthma (DESTINATION): a randomised, placebo-controlled extension studyAndrew Menzies-Gow, Michael E Wechsler, Christopher E Brightling, et al.
American Journal of Respiratory and Critical Care Medicine|February 8, 2024
Biomarkers Associated with Lung Function Decline and Dupilumab Response in Patients with AsthmaIan D Pavord, Lucia De Prado Gómez, Guy Brusselle, et al.
The European Respiratory Journal|May 3, 2017
Associations in asthma between quantitative computed tomography and bronchial biopsy-derived airway remodellingRachid Berair, Ruth Hartley, Vijay Mistry, et al.
The Journal of Allergy and Clinical Immunology|July 1, 2025
Analysis of airway inflammation demonstrates a mechanism for T2-biologic failure in asthmaP Jane McDowell, Adnan Azim, John Busby, et al.
Respiratory Medicine|September 1, 2016
Effects of older age and age of asthma onset on clinical and inflammatory variables in severe refractory asthmaRekha Chaudhuri, Charles McSharry, Liam G Heaney, et al.
ERJ Open Research|August 5, 2021
High serum granulocyte-colony stimulating factor characterises neutrophilic COPD exacerbations associated with dysbiosisArindam Chakrabarti, Jordan S Mar, David F Choy, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|May 2, 2024
Biomarkers and clinical outcomes after tezepelumab cessation: Extended follow-up from the 2-year DESTINATION studyChristopher E Brightling, Marco Caminati, Jean-Pierre Llanos, et al.
Respiratory Research|July 31, 2010
Expression and activation of the oxytocin receptor in airway smooth muscle cells: Regulation by TNFalpha and IL-13Yassine Amrani, Farhat Syed, Chris Huang, et al.
The Lancet. Respiratory Medicine|December 8, 2024
Augmenting clinical trials in asthma through digital technology, decentralised designs, and person-centric endpoints: opportunities and challengesJob F M van Boven, Richard W Costello, Kit C B Roes, et al.
Pageof 30